The DPP-4 inhibitor vildagliptin increases β-cell mass in rodents. - Duttaroy,A.; Voelker,F.; Zhang,X.; Ren,X.; Merriam,K.; Qiu,L.; Knight,S.; Chen,H.; Hughes,T.; Burkey,B. (Diabetologia, 2005)